Since NRP‐1/CD304 is a useful marker for identifying human pDCs, it has a high sensitivity in the diagnosis of blastic plasmacytoid dendritic cell neoplasm (BPDCN) combined with other markers. The gene discussed is NRP1; the disease is CD4+/CD56+ hematodermic neoplasm.